TGFBR2 and lung adenocarcinoma: The results demonstrated that prognosis was worse for patients with lung adenocarcinoma where TGFβR2 expression was >1.99 fold higher than in normal tissues (HR = 1.28 (95% CI, 1.01–1.63), P = 0.038).